500 related articles for article (PubMed ID: 12132492)
1. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
3. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
Ohnishi S; Kasanuki H
J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
[TBL] [Abstract][Full Text] [Related]
4. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
Cappato R
Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
[TBL] [Abstract][Full Text] [Related]
6. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
7. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
[TBL] [Abstract][Full Text] [Related]
8. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
9. [Implantable cardioverter-defibrillator(ICD)].
Kurita T
Nihon Rinsho; 2002 Jul; 60(7):1353-60. PubMed ID: 12136614
[TBL] [Abstract][Full Text] [Related]
10. Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.
Tsai CT; Huang SK; Lin JL; Lai LP;
Pacing Clin Electrophysiol; 2003 Nov; 26(11):2083-90. PubMed ID: 14622308
[TBL] [Abstract][Full Text] [Related]
11. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
Wilkoff BL; Hess M; Young J; Abraham WT
J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1002-9. PubMed ID: 15363071
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
13. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
Prystowsky EN
Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
[TBL] [Abstract][Full Text] [Related]
14. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
Farré J; Cabrera JA; Romero J; Rubio JM
Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with implantable defibrillator].
Roseva-Nielsen NG; Svendsen JH
Ugeskr Laeger; 2003 Jun; 165(25):2556-60. PubMed ID: 12854265
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with the implantable cardioverter defibrillator (ICD)].
Jordaens LJ
Verh K Acad Geneeskd Belg; 1997; 59(2):107-33. PubMed ID: 9210850
[TBL] [Abstract][Full Text] [Related]
18. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
Singh S; Murawski MM
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
